National · Regional · Global Impact

Science That Does Not
Stay in the Laboratory

Four decades of research that protects lives, shapes health policy, informs disease response, and advances the scientific knowledge that governs health decisions across Kenya, Africa, and the world. This is what KEMRI's impact looks like — quantified, documented, and visibly proud.

View Impact Dashboard Read Impact Stories

Kenyan Counties with KEMRI Presence

50+

Policy Briefs Informing Decision-Makers

40+

Years of Continuous Public Service

Impact at a Glance

KEMRI's Institutional Impact — Quantified

Four decades of continuous scientific operation, translated into the metrics that matter. Every number below represents real science, real policy, and real lives.

🏛️

Specialist Research Centres

Spanning Kenya from Kisumu to Mombasa, Nairobi to Turkana

👥

4,000+

Scientific Staff

One of Africa's largest health research workforces, in a single institution

📍

Kenyan Counties

National research and public health presence across every county in Kenya

📋

50+

Policy Briefs

Translating research evidence into guidance for Kenya's health decision-makers

🔬

Thematic Research Areas

From infectious disease and genomics to drug development and public health systems

📅

40+

Years of Service

Continuous scientific service to Kenya's public health since establishment in 1979

🤝

30+

International Partners

Active research collaborations with leading global scientific and funding institutions

📄

1,000+

Peer-Reviewed Publications

Contributing to the global scientific evidence base on Africa's health challenges

Download Impact Report 2024 View All Publications

Health Outcomes

Measurable Improvements in the Health of Kenyan Populations

KEMRI's research does not exist in isolation from the health system it serves. Through four decades of epidemiological research, clinical study, and public health engagement, KEMRI has contributed to documented improvements in how Kenya detects, responds to, and prevents the diseases that most burden its population.

Malaria Control Evidence

KEMRI's longitudinal malaria cohort studies in western Kenya have generated the clinical evidence base that informed Kenya's malaria treatment guidelines updates, contributing to improved case management for millions of Kenyans in endemic regions.

Infectious Disease · Western Kenya

Pathogen Surveillance Intelligence

KEMRI's genomic surveillance programme provides near-real-time pathogen intelligence to Kenya's Ministry of Health and Africa CDC, enabling evidence-based outbreak response rather than reactive containment.

Genomic Surveillance · National & Continental

Cancer Epidemiology and Control

KEMRI's NCD epidemiology research provided the cancer incidence projections and risk factor data that directly informed Kenya's updated National Cancer Control Strategy 2023–2027, shaping cancer prevention investment across the country.

Non-Communicable Disease · National Policy

Maternal and Child Health

KEMRI's maternal health research in Kisumu, Homa Bay, and Siaya counties demonstrated the effectiveness of integrated postnatal care models, providing the evidence basis for the scale-up of these models across Kenya's highest-burden counties.

SRACH · Western Kenya Counties

Research Output Growth — Selected Indicators

Illustrative trend across KEMRI's major research domains, 2019–2024

Peer-Reviewed Publications High

Consistent upward trend across all research areas

Policy Briefs Produced High

Growing policy translation output across health domains

International Collaborations High

Expanding global research partnership network

Genomic Sequences Generated Very High

Surge in genomic surveillance capacity post-2020

Clinical Trials Hosted Growing

Increasing clinical research services demand

Research Portfolio Distribution by Domain

Infectious Diseases (35%)

Genomics (20%)

Public Health (20%)

NCDs (15%)

Drug Development (10%)

Policy Influence

Research That Reaches Decision-Makers and Changes Health Policy

KEMRI's most significant contribution to Kenyan health is not measured in publications alone — it is measured in the policies those publications have changed, the guidelines they have updated, and the health system decisions they have informed. The case studies below document that pathway with specificity.

KEMRI produces policy briefs across all major health domains — COVID-19, genomic surveillance, malaria, cancer care, Universal Health Coverage, antimicrobial resistance, and health financing — and maintains formal and informal advisory relationships with Kenya's Ministry of Health, county health departments, and international health bodies including WHO and Africa CDC.

Access Full Policy Brief Library

50+

Policy Briefs Published

Translating KEMRI research into actionable evidence for Kenya's health decision-makers across government, health system, and development policy domains.

Non-Communicable Diseases · National Policy

KEMRI Cancer Epidemiology Research Informs Kenya's National Cancer Control Strategy 2023–2027

KEMRI's five-year multi-county cancer registry expansion — tracking incidence, stage at diagnosis, and survival outcomes across Kenya — provided the epidemiological evidence base that the Ministry of Health required to update Kenya's National Cancer Control Strategy. KEMRI's projections for breast, cervical, and prostate cancer incidence through 2030 directly shaped investment prioritisation in the revised strategy.

Research to Policy Pathway

Registry Data Collection → Incidence Analysis → Policy Brief → MoH Consultation → Strategy Adoption

Documented Policy Outcome

KEMRI cancer incidence projections cited in Kenya National Cancer Control Strategy 2023–2027, shaping prevention and screening investment priorities nationally.

Genomic Surveillance · Continental Health Security

KEMRI Genomic Data Informs Africa CDC's Continental Pandemic Preparedness Framework

KEMRI's Centre for Virus Research contributed Kenya's pathogen genomic surveillance data — covering respiratory viruses, arboviruses, and emerging pathogens — to Africa CDC's continental genomic intelligence network. This contribution directly informed the design of Africa CDC's Pathogen Genomics Initiative, which uses KEMRI's operational model as a reference for national-level surveillance system development across 11 African countries.

Research to Policy Pathway

Genomic Surveillance → Data Contribution → Africa CDC Analysis → Framework Design

Documented Policy Outcome

KEMRI's surveillance model adopted as the reference framework for Africa CDC's Pathogen Genomics Initiative across 11 member states.

Health Systems · Universal Health Coverage

KEMRI Health Financing Research Shapes NHIF Expansion Design for Kenya's Lowest-Income Counties

KEMRI's Centre for Public Health Research conducted a five-year evaluation of Kenya's National Health Insurance Fund coverage patterns and their equity implications across Kenya's 47 counties. The research documented significant coverage gaps in the lowest-income rural counties and identified the structural barriers preventing NHIF uptake among the populations who would most benefit from coverage. KEMRI's policy brief provided specific, evidence-based recommendations for targeted NHIF expansion design.

Research to Policy Pathway

Equity Research → County Analysis → Policy Brief → MoH Advisory

Documented Policy Outcome

KEMRI equity findings incorporated into Kenya's UHC implementation planning, informing differentiated NHIF premium structures for low-income populations.

Disease Response

KEMRI's Role in Kenya's Health Emergency History

KEMRI does not only conduct health research. When Kenya faces a health emergency — an outbreak, a pandemic, a disease surge — KEMRI is at the response frontline, providing the scientific intelligence that shapes the national response. This is not incidental to KEMRI's mandate. It is central to it.

Rapid Genomic Characterisation Pathogen sequencing and characterisation within 72 hours of sample receipt

National Sentinel Surveillance Real-time disease intelligence from sentinel sites across all 47 counties

Field Investigation Capacity Rapid deployment of epidemiological investigation teams to outbreak sites

Real-Time Data to Decision-Makers Direct scientific advisory to Ministry of Health during health emergencies

Explore Surveillance Capabilities

2020–2023

COVID-19 Pandemic Response

KEMRI established Kenya's primary COVID-19 testing and genomic surveillance infrastructure within weeks of the pandemic's arrival in Kenya. KEMRI scientists sequenced Kenya's SARS-CoV-2 variants in real time, provided epidemiological analysis to the Ministry of Health, and conducted research on vaccine immunogenicity and COVID-19 clinical outcomes in Kenyan populations.

🔬 Lead scientific advisor to Kenya's COVID-19 response; first to characterise Kenyan SARS-CoV-2 variant strains

2019

Kala-Azar (Visceral Leishmaniasis) Outbreak — Marsabit County

KEMRI's parasitology team deployed to Marsabit County following reports of an unusual clustering of visceral leishmaniasis cases. KEMRI provided rapid diagnostic confirmation, sand fly vector surveillance, and epidemiological mapping that allowed the Ministry of Health to deploy targeted vector control and case treatment interventions.

🔬 Diagnostic confirmation, vector surveillance, and epidemiological mapping provided to MoH within 2 weeks

2018–2019

Rift Valley Fever Recurrence — Northern Kenya

KEMRI's Centre for Virus Research provided rapid serological and molecular confirmation of Rift Valley Fever cases in Garissa, Wajir, and Mandera counties. KEMRI's environmental and ecological analysis identified the rainfall and vector population conditions predicting outbreak risk, informing Kenya's predictive surveillance framework.

🔬 Rapid diagnostic support and ecological risk modelling contributed to national outbreak preparedness strategy

2014–2016

West African Ebola Epidemic — Regional Preparedness

As the West African Ebola epidemic threatened regional spread, KEMRI led Kenya's Ebola preparedness response — establishing laboratory diagnostic capacity, training frontline health workers in personal protective equipment use, and developing Kenya's Ebola screening protocols for ports of entry. Kenya's preparedness was repeatedly cited by WHO as among the strongest in sub-Saharan Africa.

🔬 Lead institution for Kenya's Ebola laboratory preparedness; WHO cited Kenya as regional preparedness model

2009

H1N1 Influenza Pandemic

KEMRI provided Kenya's primary H1N1 diagnostic capacity and conducted surveillance to characterise the spread and severity of pandemic influenza across Kenya's regions. KEMRI's data on H1N1 clinical presentations in Kenyan populations contributed to the global understanding of pandemic influenza epidemiology in tropical African settings.

🔬 Primary national H1N1 diagnostic laboratory; surveillance data contributed to WHO global pandemic analysis

National Reach

KEMRI Is Not a Nairobi Institution. It Is a National One.

KEMRI's operational presence spans the full geographic breadth of Kenya — from the shores of Lake Victoria in western Kenya to the coast of the Indian Ocean, from the arid and semi-arid lands of northern Kenya to the highlands of the Rift Valley. That national reach is not incidental. It is the foundation of KEMRI's value as Kenya's national health research institution — the reason its research is representative, its surveillance is comprehensive, and its public health intelligence is nationally meaningful.

Counties with KEMRI research or public health presence

Specialist research centres across Kenya

Major field research stations

4,000+

Staff deployed across the country

Kisumu & Homa Bay — Major field research stations, malaria cohort studies

Nairobi — Primary research centre hub, clinical research, genomics

Mombasa — Coastal field station, tropical disease research

Kilifi — KEMRI-Wellcome Trust Programme, paediatric health research

Marsabit, Turkana, Garissa — Arid lands disease surveillance and response

All 47 counties — Disease surveillance sentinel site network

KEMRI Research & Field Presence — Kenya

Major Research Centres

Field Stations

Sentinel Sites

Regional & Global Impact

KEMRI's Impact Beyond Kenya

KEMRI's science is rooted in Kenya but its impact reaches Africa and the world. Select a dimension to explore.

Kenya's Contribution to Africa's Scientific Sovereignty

At a moment when Africa is claiming its scientific sovereignty — when the African Union is building continental pharmaceutical manufacturing capacity, when Africa CDC is establishing continental disease intelligence infrastructure, when the genomics of African populations are finally being studied by African scientists — KEMRI is at the centre of that claim.

KEMRI's contributions to the African scientific landscape go beyond Kenya's borders in three specific dimensions: continental disease surveillance, scientific capacity building, and the provision of a model for what a well-funded, well-governed African national research institution can achieve.

Africa CDC Partnership: KEMRI's genomic surveillance data feeds directly into Africa CDC's continental health intelligence system, making Kenya one of the primary data contributors to the AU's disease early-warning network.

Pan-African Capacity Building: KEMRI has trained scientists from more than 15 African countries through its graduate programs, fellowship schemes, and collaborative research initiatives — contributing directly to African scientific human capital.

African Genomics Leadership: KEMRI's participation in the H3Africa Consortium and the East African Pharmacogenomics Network has established Kenya as a leading contributor to African genome science — correcting the global underrepresentation of African genetic data.

East African Research Hub: KEMRI serves as the anchor institution for regional multi-country research programs spanning Kenya, Uganda, Tanzania, Rwanda, and Ethiopia — positioning Nairobi as East Africa's health research capital.

KEMRI's African Collaborative Network

Africa CDC

Continental Disease Surveillance

Data Partner

Uganda Virus Research Institute

Joint virology research programs

Research

Ifakara Health Institute

Malaria and tropical disease collaboration

Research

South African MRC

NCD and genomics partnership

Research

Nigeria CDC

Surveillance system capacity support

Capacity

KEMRI's Contribution to Global Scientific Knowledge

The health challenges that KEMRI studies in Kenya — malaria, HIV, tuberculosis, emerging infectious diseases, antimicrobial resistance, non-communicable disease in African populations — are among the most consequential in global health science. The findings KEMRI generates are not locally relevant. They are globally significant. They fill gaps in the evidence base that institutions based in Europe and North America cannot fill, because they are studying populations and contexts that those institutions cannot access.

WHO Collaborating Centre: KEMRI's Centre for Virus Research holds WHO Collaborating Centre status for respiratory pathogen genomic surveillance — one of only a handful on the African continent.

Nature Microbiology Publication: KEMRI's first publication in Nature Microbiology in 2023 characterised three novel respiratory pathogen lineages detected through Kenya's national surveillance system — a landmark for African health science.

WHO Treatment Guidelines: KEMRI malaria clinical trial data has contributed to multiple updates to WHO global malaria treatment guidelines, influencing treatment protocols in over 90 malaria-endemic countries.

H3Africa Consortium: KEMRI is a founding member of H3Africa — the Human Heredity and Health in Africa Consortium — which has transformed African genomic research capacity and the representation of African genomes in global databases.

KEMRI's Global Research Network

World Health Organisation

Collaborating Centre — Genomic Surveillance

WHO Partner

Wellcome Trust / Sanger Institute

Genomics and infectious disease research

Funder

NIH / Fogarty International Center

Research training and collaborative science

Funder

CDC / USAID

Public health program support

Funder

London School of Hygiene & Tropical Medicine

Joint research and training programs

Research

A Network of World-Class Partners Who Choose to Work with KEMRI

The quality and breadth of KEMRI's international partnership network is one of the most reliable indicators of its scientific standing. The organisations that choose to partner with KEMRI — to co-fund research, to collaborate on studies, to host joint programs — are among the world's most discerning scientific institutions. Their choice to work with KEMRI is itself an endorsement of KEMRI's quality.

KEMRI maintains active research partnerships with institutions in the United Kingdom, United States, Germany, Netherlands, Sweden, and Australia, in addition to its extensive African collaborative network. These partnerships span the full spectrum of research collaboration — from multi-year co-funded research programs to specific study co-investigations, from training exchanges to shared infrastructure.

30+ Active International Partnerships with research institutions, funding organisations, and government health bodies across six continents.

Joint publications with partner institutions in the Lancet, Nature, NEJM, PLOS Medicine, and other leading international journals — evidence of genuine collaborative science, not nominal affiliation.

Training exchange programs with partner universities, hosting scientists from partner institutions for field experience and research attachment in Kenya.

Explore Partnership Opportunities

Selected International Partners

Wellcome Trust

Major research funder — KEMRI-Wellcome Programme

Lead Funder

Johns Hopkins Bloomberg School

Public health and epidemiology collaboration

Research

Bernhard Nocht Institute

Tropical medicine research partnership

Research

Amsterdam UMC

HIV and infectious disease collaboration

Research

Burnet Institute

HIV and sexual health research

Research

Impact Stories

Science Translated into
Human Consequence

Behind every metric is a story. Behind every publication is a person whose health was improved, a policy that was changed, or a disease that was better understood. These are some of those stories.

All Stories

Featured Impact Story · Genomic Surveillance

72 Hours: How KEMRI's Genomic Surveillance System Stopped an Outbreak Before It Spread

When an unusual respiratory illness cluster appeared in a Kenyan county health facility, KEMRI's Centre for Virus Research had sequenced the pathogen and delivered actionable intelligence to the Ministry of Health within three days. This is the story of what that infrastructure makes possible.

In late 2023, a county public health officer in central Kenya reported an unusual clustering of severe respiratory illness among previously healthy adults. Within 24 hours of sample receipt at KEMRI's Centre for Virus Research, the genomic sequencing process had begun. Within 72 hours, KEMRI had characterised the causative pathogen, identified its phylogenetic lineage, and delivered a full genomic intelligence report to Kenya's Ministry of Health, enabling the deployment of a targeted, evidence-based response before the cluster had grown beyond its initial geographic boundary.

This outcome — rapid characterisation, targeted response, outbreak contained — was only possible because of a decade of infrastructure investment: the sequencing equipment, the trained scientists, the bioinformatics pipelines, and the established relationship with the Ministry of Health that meant KEMRI's findings were acted upon immediately. It is what KEMRI's genomic surveillance programme was built to do.

Genomic Surveillance Outbreak Response WHO Collaborating Centre

Explore the Research

Malaria Research · Western Kenya

Thirty Years of Watching Malaria — and What the Data Reveals About Immunity

KEMRI's Kisumu field station has followed the same community for three decades, watching how malaria immunity develops, wanes, and responds to interventions. The data generated has shaped global understanding of how natural immunity to P. falciparum works — and what that means for vaccine development.

Natural Products · Drug Discovery

From a Kenyan Forest to a Drug Candidate: The Story of Compound KMR-7

A compound isolated from a medicinal plant used by traditional healers in Kenya's highlands has demonstrated potent activity against artemisinin-resistant malaria in preclinical testing. For the first time, a novel antimalarial candidate has been wholly developed by an African research institution.

Health Systems · UHC

The Numbers Behind the Policy: How KEMRI Data Changed Kenya's NHIF Expansion

Five years of health financing research across all 47 counties revealed a stark geographic inequality in NHIF coverage. KEMRI's evidence was placed directly in front of Kenya's health policymakers — and the subsequent NHIF expansion design reflected what KEMRI's data had shown.

Read All KEMRI Impact Stories

Scientific Contributions

Selected Publications &
Scientific Achievements

All Publications

Original Research · High Impact

Real-time Genomic Surveillance Reveals Emergence and Spread of Novel Respiratory Pathogen Lineages in Kenya's Lake Victoria Basin

Kariuki J, Mutua S, Wambua A, Centre for Virus Research Team et al.

Nature Microbiology, 2023

KEMRI's first publication in Nature Microbiology. Reports the identification and genomic characterisation of three novel respiratory pathogen lineages detected through Kenya's national genomic surveillance system — establishing Kenya as a global model for real-time pathogen surveillance.

Longitudinal Cohort · Malaria Immunology

Longitudinal Dynamics of Anti-Malarial Immunity in a High-Transmission Cohort in Western Kenya: Implications for Vaccine Development

Wambua A, Kariuki J, Odhiambo G, et al.

The Lancet Infectious Diseases, 2024

A decade-long cohort study tracking immune responses to P. falciparum antigens in 2,400 participants in Kisumu County, generating insights that directly inform malaria vaccine development pipelines including the RTS,S and R21 vaccine programs.

Health Systems · Policy Translation

Universal Health Coverage in Kenya: Evidence-Based Recommendations for Equitable NHIF Expansion Across Rural Counties

KEMRI Centre for Public Health Research

KEMRI Policy Brief Series, 2024

Drawing on five years of health financing research across Kenya's 47 counties, this policy brief provides actionable recommendations for how NHIF expansion can be designed to reach Kenya's lowest-income rural populations — adopted by the Ministry of Health in 2024 planning processes.

Engage with KEMRI

KEMRI's Impact Is Only as Large as the Resources Behind It

The research that protects Kenyan lives, informs health policy, and advances global scientific knowledge depends on the funders, partners, and collaborators who make it possible. If the impact documented here matters to you, there is a role for your organisation in producing more of it.

Fund KEMRI Research Explore Partnerships Contact Our Team

Science That Does NotStay in the Laboratory

KEMRI's Institutional Impact — Quantified

Measurable Improvements in the Health of Kenyan Populations

Research That Reaches Decision-Makers and Changes Health Policy

KEMRI Cancer Epidemiology Research Informs Kenya's National Cancer Control Strategy 2023–2027

KEMRI Genomic Data Informs Africa CDC's Continental Pandemic Preparedness Framework

KEMRI Health Financing Research Shapes NHIF Expansion Design for Kenya's Lowest-Income Counties

KEMRI's Role in Kenya's Health Emergency History

KEMRI Is Not a Nairobi Institution. It Is a National One.

KEMRI's Impact Beyond Kenya

Kenya's Contribution to Africa's Scientific Sovereignty

KEMRI's Contribution to Global Scientific Knowledge

A Network of World-Class Partners Who Choose to Work with KEMRI

Science Translated intoHuman Consequence

72 Hours: How KEMRI's Genomic Surveillance System Stopped an Outbreak Before It Spread

Thirty Years of Watching Malaria — and What the Data Reveals About Immunity

From a Kenyan Forest to a Drug Candidate: The Story of Compound KMR-7

The Numbers Behind the Policy: How KEMRI Data Changed Kenya's NHIF Expansion

Selected Publications &Scientific Achievements

Real-time Genomic Surveillance Reveals Emergence and Spread of Novel Respiratory Pathogen Lineages in Kenya's Lake Victoria Basin

Longitudinal Dynamics of Anti-Malarial Immunity in a High-Transmission Cohort in Western Kenya: Implications for Vaccine Development

Universal Health Coverage in Kenya: Evidence-Based Recommendations for Equitable NHIF Expansion Across Rural Counties

KEMRI's Impact Is Only as Large as the Resources Behind It

Science That Does Not
Stay in the Laboratory

Science Translated into
Human Consequence

Selected Publications &
Scientific Achievements